Cargando…
Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma
Evidence supporting rechallenge in patients responding to first exposure to trabectedin is limited. We report on a 39-year-old woman with advanced high-grade undifferentiated sarcoma (US) retreated twice with trabectedin after first response. The patient presented in June 2006 with an abdominal mass...
Autores principales: | Baldi, Giacomo G., Di Donato, Samantha, Fargnoli, Rossana, Dona, Manjola, Bertulli, Rossella, Parisi, Elisabetta, Fantini, Lorenzo, Sbaraglia, Marta, Panella, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010279/ https://www.ncbi.nlm.nih.gov/pubmed/27348763 http://dx.doi.org/10.1097/CAD.0000000000000398 |
Ejemplares similares
-
Trabectedin Drug Holiday and Rechallenge in Soft Tissue Sarcomas: Report of 4 Cases and Literature Review
por: Pierantoni, Francesco, et al.
Publicado: (2019) -
Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015) -
Trabectedin for soft tissue sarcoma
Publicado: (2021) -
The Role of Trabectedin in Soft Tissue Sarcoma
por: Nakamura, Tomoki, et al.
Publicado: (2022) -
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
por: Recine, Federica, et al.
Publicado: (2017)